Australija - anglų - APVMA (Australian Pesticides and Veterinary Medicines Authority)

randlab australia pty ltd - sulfadiazine - unknown - sulfadiazine sulfanyl active 0.0 - active constituent

Kanada - anglų - Health Canada

stanley pharmaceuticals, a division of vita health products inc. - sulfadiazine - tablet - 500.5mg - sulfadiazine 500.5mg - sulfonamides

Malta - anglų - Malta Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - sulfadiazine - tablet - sulfadiazine 500 mg - antibacterials for systemic use

Australija - anglų - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - trimethoprim; sulfadiazine - oral tablet - trimethoprim pyrimidine active 80.0 mg/tb; sulfadiazine sulfanyl active 400.0 mg/tb - antibiotic & related - dog | bitch | castrate | puppy - bacterial infection | organisms sensitive to combination of | amoxycillin sensitive bacteria | associated with viral disease | gram negative organisms | gram positive organisms | post parturient bacterial infe | primary bacterial infection | sulfadiazine sensitive bacteri | trimethoprim sensitive bacteri | tylosin sensitive bacteria

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

medsource pharmaceuticals - silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) - silver sulfadiazine 10 mg in 1 g

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

a-s medication solutions - silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) -      silver sulfadiazine cream, usp 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns.      silver sulfadiazine cream, usp 1% is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation.      because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream, usp 1% should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.      geriatric use. of the total number of subjects in clinical studies of silver sulfadiazine cream, usp 1% seven percent were 65 years of age and over. no overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater s

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) -      silver sulfadiazine cream, usp 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns.      silver sulfadiazine cream, usp 1% is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation.      because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream, usp 1% should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.      geriatric use. of the total number of subjects in clinical studies of silver sulfadiazine cream, usp 1% seven percent were 65 years of age and over. no overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater s

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

a-s medication solutions - silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) -      silver sulfadiazine cream, usp 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns.      silver sulfadiazine cream, usp 1% is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation.      because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream, usp 1% should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.      geriatric use. of the total number of subjects in clinical studies of silver sulfadiazine cream, usp 1% seven percent were 65 years of age and over. no overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.      pediatric use. safety and effectiveness in children have not been established. (see contraindications)

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

unit dose services - silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) -      silver sulfadiazine cream, usp 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns.      silver sulfadiazine cream, usp 1% is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation.      because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream, usp 1% should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.      geriatric use. of the total number of subjects in clinical studies of silver sulfadiazine cream, usp 1% seven percent were 65 years of age and over. no overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

medsource pharmaceuticals - silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) -      silver sulfadiazine cream, usp 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns.      silver sulfadiazine cream, usp 1% is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation.      because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream, usp 1% should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.      geriatric use. of the total number of subjects in clinical studies of silver sulfadiazine cream, usp 1% seven percent were 65 years of age and over. no overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients,